Concepedia

Joo Ern Ang

JE

Statistics

Publications

32

Citations

3.1K

H-Index

20

Active since

2008

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

Royal Marsden Hospital

Cancer Research UK

University College London

Joo Ern Ang is an author at Institute of Cancer Research specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2008–2021

32

Publications

32

Effect of sleep deprivation on the human metabolome

Sarah K. Davies, Joo Ern Ang, Victoria L. Revell et al. · Proceedings of the National Academy of Sciences · 2014 · 525 citations · Full text

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With <i>BRCA1</i> or <i>BRCA2</i> Mutations and Recurrent Ovarian Cancer

Stan B. Kaye, Jan Lubiński, Ursula A. Matulonis et al. · Journal of Clinical Oncology · 2011 · 472 citations

First-in-Human Phase I Study of Pictilisib (GDC-0941), a Potent Pan–Class I Phosphatidylinositol-3-Kinase (PI3K) Inhibitor, in Patients with Advanced Solid Tumors

Debashis Sarker, Joo Ern Ang, Richard D. Baird et al. · Clinical Cancer Research · 2014 · 341 citations · Full text

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

David Olmos, Hendrik‐Tobias Arkenau, Joo Ern Ang et al. · Annals of Oncology · 2008 · 247 citations · Full text

, , +8

Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

Johann S. de Bono, Nicole Concin, David S. Hong et al. · The Lancet Oncology · 2019 · 217 citations · Full text

, , +10

Rows per page

1–5 of 32